Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
What’s Your Call?
Collective community sentiment on Praveg Ltd
Your Vote -
Buy
50.00%
Hold
31.25%
Sell
18.75%
50.00%
32 users have voted
Option Chain
Analyzes market sentiment, predicts Praveg Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Praveg L - Announcement under Regulation 30 (LODR)-Press Release / Media Release
-
Praveg L - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
-
Praveg L has submitted to BSE the Shareholding Pattern for the Period Ended February 13, 2025
-
Praveg L - Announcement under Regulation 30 (LODR)-Scheme of Arrangement
-
Praveg L - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
-
Praveg L - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Praveg L - Non-Exercise Of Conversion Of Convertible Warrants
-
Praveg L - Announcement under Regulation 30 (LODR)-Allotment
-
Praveg L - Announcement under Regulation 30 (LODR)-Investor Presentation
-
Praveg L - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report
-
Praveg L - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
-
Praveg L - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
-
Praveg L - Announcement under Regulation 30 (LODR)-Press Release / Media Release
-
Praveg L - Statement On Deviation Or Variation Under Regulation 32 Of The SEBI (LODR) Regulations, 2015
-
Praveg L - Integrated Filing (Financial)
-
Praveg L - Grant Of Options To Eligible Employees As Per Praveg's ESOP Plan, 2024
-
Praveg L Q3 net profit down 5.56% at Rs 7.64 cr
-
Praveg L - Unaudited Consolidated And Standalone Financial Results For The Quarter Ended December 31, 2024
-
Praveg L - Board Meeting Outcome for Outcome Of Board Meeting Held On February 11, 2025
-
Praveg L - Grant Of Options To Eligible Employees As Per Praveg's ESOP Plan, 2024
-
Praveg L - Grant Of Options To Eligible Employees As Per Praveg's ESOP Plan, 2024
-
Praveg L - Grant Of Options To Eligible Employees As Per Praveg's ESOP Plan, 2024
-
Praveg L - Grant Of Options To Eligible Employees As Per Praveg's ESOP Plan, 2024
-
Praveg L - Grant Of Options To Eligible Employees As Per Praveg's ESOP Plan, 2024
-
Praveg L - Board Meeting Intimation for Approval And Consideration Of Unaudited Financial Results For The Quarter Ended Decem
-
Praveg L - Announcement under Regulation 30 (LODR)-Press Release / Media Release
-
Praveg L has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2024
-
Praveg L - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Praveg L - Board Meeting Outcome for Outcome Of Board Meeting - Approval Of Postal Ballot Notice
-
Praveg L - Announcement under Regulation 30 (LODR)-Press Release / Media Release
-
Praveg L - Announcement under Regulation 30 (LODR)-Press Release / Media Release
-
Praveg announces Hotel Management agreement with the Indian Hotels
Key fundamentals
Evaluate the intrinsic value of Praveg Ltd stock
Name | March-24 | March-23 | March-22 | March-21 | March-20 |
---|---|---|---|---|---|
Assets | 287.7886 | 112.8745 | 30.9841 | 20.043 | 15.8414 |
Liabilities | 287.7886 | 112.8745 | 30.9841 | 20.043 | 15.8414 |
Equity | 24.5326 | 20.9221 | 18.4841 | 18.4841 | 18.4841 |
Gross Profit | 29.0812 | 44.8642 | 19.7012 | 15.8718 | 6.3624 |
Net Profit | 12.8935 | 28.3802 | 12.2278 | 10.7989 | 3.6445 |
Cash From Operating Activities | 16.9163 | 25.2123 | 6.5971 | 14.1913 | 2.5561 |
NPM(%) | 14.1 | 33.63 | 27.17 | 23.85 | 6.12 |
Revenue | 91.4175 | 84.3792 | 44.9886 | 45.2705 | 59.5179 |
Expenses | 62.3363 | 39.515 | 25.2874 | 29.3987 | 53.1555 |
ROE(%) | 2.94 | 6.47 | 2.78 | 2.46 | 0.83 |
Corporate Action
XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
---|
Peers
Other companies within the same industry or sector that are comparable to Praveg Ltd
Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
---|---|---|---|---|---|---|
Albert David Ltd | 809.25 | -0.64 | 11.41 | 277.06 | 1321.50 | 1.42 |
Lotus Eye Hospital and Institute Ltd | 58.19 | 1.50 | 237.75 | 1009.56 | 14.01 | 0.88 |
Bharat Immunological and Biologicals Corporation Ltd | 21.32 | -1.30 | 0.00 | 2096.17 | -39.50 | 0.00 |
Astec Lifesciences Ltd | 654.90 | -5.39 | 0.00 | 951.92 | -239.30 | 0.00 |
Company Info
Sword and Shield Pharma Ltd was incorporated as a Public Limited company on 28th February, 1995 with the Registrar of Companies, Gujarat State, Ahmedabad and obtained Certificate of Commencement of Business on 7th March, 1995. The Copmany was promoted by experienced entrepreneurs with a proven track record of marketing of different pharmaceuucal formulations. The Company has proposed the project at the cost of Rs.515.00 Lacs for manufacturing and marketing of different pharmaceutical formulations. The Company has started the implementation of the project by acquisition of land, admeasuring 3650 sq. yards, at village Indrad, Dist. Kadi, Gujarat. The N.A. Approval for the land is already obtained by the Company. The necessary application to Gujarat Electricity Board and Gujarat Pollution Board are already being made. 2020 -Company name has changed to Praveg Communications (India) Ltd. from Sword & Shield Pharma Ltd.. 2021 -Company Has Been Recognized As The Runner Up In The Category Of Best Eco Resort In Gujarat At Gujarat Travel & Tourism Excellence Award 2021.
Sword and Shield Pharma Ltd was incorporated as a Public Limited company on 28th February, 1995 with the Registrar of Companies, Gujarat State, Ahmedabad and obtained Certificate of Commencement of Business on 7th March, 1995. The Copmany was promoted by experienced entrepreneurs with a proven track record of marketing of different pharmaceuucal formulations. The Company has proposed the project at the cost of Rs.515.00 Lacs for manufacturing and marketing of different pharmaceutical formulations. The Company has started the implementation of the project by acquisition of land, admeasuring 3650 sq. yards, at village Indrad, Dist. Kadi, Gujarat. The N.A. Approval for the land is already obtained by the Company. The necessary application to Gujarat Electricity Board and Gujarat Pollution Board are already being made. 2020 -Company name has changed to Praveg Communications (India) Ltd. from Sword & Shield Pharma Ltd.. 2021 -Company Has Been Recognized As The Runner Up In The Category Of Best Eco Resort In Gujarat At Gujarat Travel & Tourism Excellence Award 2021.
Read More
Parent Organisation
Praveg Ltd.
Founded
28/02/1995
Managing Director
NSE Symbol
FAQ
The current price of Praveg Ltd is
The 52-week high for Praveg Ltd is
The market capitalization of Praveg Ltd is currently
This value can fluctuate based on stock price movements and changes in the number of shares outstanding.To buy Praveg Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Praveg Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Praveg Ltd shares.
The CEO of Praveg Ltd is , who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.